CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial

OBJECTIVE: An investigator-initiated, multicenter, randomized, placebo-controlled, double-blind clinical trial to determine whether coenzyme Q10 (CoQ10) is safe, well tolerated, and effective in slowing functional decline in progressive supranuclear palsy (PSP). METHODS: Sixty-one participants recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Apetauerova, Diana, Scala, Stephanie A., Hamill, Robert W., Simon, David K., Pathak, Subash, Ruthazer, Robin, Standaert, David G., Yacoubian, Talene A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990260/
https://www.ncbi.nlm.nih.gov/pubmed/27583276
http://dx.doi.org/10.1212/NXI.0000000000000266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990260/
https://www.ncbi.nlm.nih.gov/pubmed/27583276
http://dx.doi.org/10.1212/NXI.0000000000000266

Ejemplares similares